The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Prevalence and Predictors of Corticosteroid-Related Hyperglycemia in Hospitalized Patients
Abstract
Objective To investigate the prevalence of and risk factors for hyperglycemia in hospitalized patients receiving corticosteroids, which have been identified as an independent predictor of hyperglycemia.Methods We conducted a retrospective review of electronic medical records of patients admitted to the general medicine service at a university hospital during a 1-month period. Pharmacy charges were used to identify patients receiving high doses (> or = 40 mg/day of prednisone or the equivalent) of corticosteroids for at least 2 days. Occurrence of hyperglycemia and the presence of risk factors, including history of diabetes, duration of corticosteroid therapy, concurrent parenteral nutrition, antibiotic therapy, use of medications associated with hyperglycemia, severity of illness scores, and hospital length of stay, were determined. Patients experiencing multiple episodes of hyperglycemia (glucose levels > or = 200 mg/dL) were compared with those who had < or = 1 hyperglycemic episode. Patients without a history of diabetes were assessed separately.Results During the 1-month study period, 66 of 617 patients received high doses of corticosteroids, but only 50 of the 66 had glucose measurements. Hyperglycemia was documented in 32 of these 50 patients (64%), and multiple hyperglycemic episodes occurred in 26 (52%). A history of diabetes was documented in 12 of 26 patients who experienced multiple episodes, in comparison with 4 of 24 patients with < or = 1 episode of hyperglycemia (P = 0.035). Among patients without a history of diabetes, 19 of 34 (56%) had hyperglycemia at least once. Patients with multiple episodes of hyperglycemia had more comorbid diseases, longer duration of corticosteroid therapy, and longer duration of hospital stay.Conclusion Hyperglycemia occurs in a majority of hospitalized patients receiving high doses of corticosteroids. In light of the poor outcomes associated with hyperglycemia, protocols targeting its detection and management should be available for patients who receive corticosteroid therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The risk of DM was greater in subjects with abdominal adiposity or a genetic predisposition to DM and in those taking higher doses of GCs and for longer periods (, -).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [198]
In the citing paper
“their usage is associated with a significant number of metabolic adverse effects, including insulin resistance, visceral adiposity, dyslipidaemia and fasting and postprandial hyperglycaemia.2”
From Twenty‐four‐hour profiles of plasma glucose, insulin, C‐peptide and free fatty acid in subjects with varying degrees of glucose tolerance following short‐term, medium‐dose prednisone (20 mg/day) treatment: evidence for differing effects on insulin secretion and action (2012) · cites this paper as [2]
Citations
Cites
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Malmberg, K., Rydén, L., Efendic, S., Herlitz, J., Nicol, P., Waldenstrom, A., Wedel, H., & Welin, L. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00126-k · Cited by 1,560
Management of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Glucocorticoids and the risk for initiation of hypoglycemic therapy
Gurwitz, J. H. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420010131015 · Cited by 314
Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly
Blackburn, D. F., Hux, J. E., & Mamdani, M. (2002) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2002.10649.x · Cited by 186
Yount, R. J., & Vries, J. K. (1991) · Information Processing & Management · doi:10.1016/0306-4573(91)90091-y · Cited by 100
Steroid‐Induced Diabetes Mellitus and Related Risk Factors in Patients with Neurologic Diseases
Iwamoto, T., Kagawa, Y., Naito, Y., Kuzuhara, S., & Kojima, M. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.5.508.33355 · Cited by 79
DRUG SELECTION AND THE MANAGEMENT OF CORTICOSTEROID-RELATED DIABETES MELLITUS
Hoogwerf, B. J., & Danese, R. D. (1999) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70083-1 · Cited by 77
Is enough attention being given to the adverse effects of corticosteroid therapy?
Hougardy, Peterson, G. M., Bleasel, & Randall (2000) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2000.00284.x · Cited by 73
Managing diabetes during glucocorticoid therapy
Braithwaite, S. S., Barr, W. G., Rahman, A., & Quddusi, S. (1998) · Postgraduate Medicine · doi:10.3810/pgm.1998.11.426 · Cited by 49
Hyperglycemia in the Hospital Setting: The Case for Improved Control among Non-Diabetics
Conner, T., Flesner-Gurley, K. R., & Barner, J. C. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e308 · Cited by 28
Flagged first, then by citations
Research works printed but not linked: 1
- Inzucchi, 2003, Risk factors for poor glycemic control in a medical intensive care unit (ICU) [abstract], Diabetes., 52, A96
Cited by
Sorted by citations
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Diabetes Care · doi:10.2337/dc09-9029 · Cited by 1,444
Self-citationUmpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
Self-citationMoghissi, E. S., Korytkowski, M. T., DiNardo, M. M., EINHORN, D. F., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail‐Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Endocrine Practice · doi:10.4158/ep09102.ra · Cited by 517
Self-citationTamez-Pérez, H. E. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i8.1073 · Cited by 387
Metadata
- Authors
- Donihi, A. C., Raval, D., Saul, M., Korytkowski, M. T., & DeVita, M. A.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Donihi, Amy Calabrese
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 12
- Issue
- 4
- Pages
- 358-362
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W1977503469
- Cited by
- 246
- References
- 13
- Citations by year
- 2026: 4 · 2025: 16 · 2024: 13 · 2023: 16 · 2022: 18 · 2021: 15 · 2020: 15 · 2019: 13 · 2018: 21 · 2017: 14 · 2016: 12 · 2015: 15 · 2014: 15 · 2013: 22 · 2012: 13
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Practice (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Eli Lilly and Company
- Novo Nordisk
- Medical Center, University of Pittsburgh
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- corticosteroid-induced hyperglycemia, hospitalized patients, prednisone, risk factors, prevalence, history of diabetes, length of hospital stay, comorbidities, medical inpatients
- MeSH terms
- Adrenal Cortex Hormones, Adult, Aged, Female, Hospitalization, Humans, Hyperglycemia, Male, Middle Aged, Retrospective Studies, Risk Factors, Comorbidity, Prevalence, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
